Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Recruiting now
Conditions studied: Liver Cancer, Liver Metastases, Liver Metastasis Colon Cancer, Hepatocellular Carcinoma
In brief
The endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcome prediction in patients undergoing thermal ablation of a malignant liver tumor. The long-term objective is to establish thermal ablation as the treatment of choice for the vast majority of patients with a primary or secondary liver tumor by development of an accessible workflow that can be widely implemented in different centers performing thermal ablation. Over a time span of at least four years, data will be collected prospectively, encompassing patient information, tumor characteristics, and treatment details. Additionally, pre-, intra-, and post-procedural imaging will be systematically gathered.
Key facts
- Study ID
- NCT06179602
- Run by
- Leiden University Medical Center
- People needed
- 1500
- Starts
- 2024-01-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2025-09-10
Who can join
Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years or above
- Candidate for percutaneous thermal liver ablation as discussed in a multidisciplinary tumorboard (MDT)
- Informed consent
You may not qualify if…
- Patients lacking capacity to give informed consent.
Where it is running
- Leiden University Medical Centre — Leiden, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.